Australia, Dec. 10 -- Clinuvel Pharmaceuticals Ltd. (CUV) has reported gross short sales of 37,324 FPO shares on Dec. 6. The percent of issued capital of the company reported as short sales is 0.07 percent. The issued capital of the company is 50,060,680 shares.
Disclaimer: Curated by HT Syndication.
